News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,080 Results
Type
Article (86732)
Company Profile (703)
Press Release (763643)
Multimedia
Podcasts (138)
Webinars (18)
Section
Business (232772)
Career Advice (4130)
Deals (39748)
Drug Delivery (129)
Drug Development (91060)
Employer Resources (198)
FDA (18156)
Job Trends (17354)
News (396702)
Policy (39796)
Tag
Academia (3002)
Academic (2)
Accelerated approval (8)
Adcomms (32)
Allergies (103)
Alliances (56936)
ALS (112)
Alzheimer's disease (1535)
Antibody-drug conjugate (ADC) (186)
Approvals (18105)
Artificial intelligence (371)
Autoimmune disease (34)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (376)
Cancer (2910)
Cardiovascular disease (234)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (35)
Cell therapy (550)
Cervical cancer (24)
Clinical research (74022)
Collaboration (1041)
Company closure (3)
Compensation (654)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (318)
Cystic fibrosis (117)
Data (2878)
Decentralized trials (2)
Denatured (48)
Depression (65)
Diabetes (332)
Diagnostics (6961)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (166)
Drug pricing (147)
Drug shortages (35)
Duchenne muscular dystrophy (125)
Earnings (97418)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131252)
Executive appointments (885)
FDA (19761)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (948)
Gene editing (142)
Generative AI (36)
Gene therapy (416)
GLP-1 (899)
Government (5226)
Grass and pollen (6)
Guidances (180)
Healthcare (20911)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (171)
Immuno-oncology (8)
Indications (37)
Infectious disease (3070)
Inflammatory bowel disease (163)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (118)
Interviews (813)
IPO (17887)
IRA (53)
Job creations (5192)
Job search strategy (2861)
Kidney cancer (15)
Labor market (53)
Layoffs (582)
Leadership (25)
Legal (10130)
Liver cancer (83)
Lung cancer (414)
Lymphoma (200)
Machine learning (9)
Management (65)
Manufacturing (412)
MASH (92)
Medical device (14693)
Medtech (14698)
Mergers & acquisitions (22533)
Metabolic disorders (881)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (38)
Neuroscience (2248)
NextGen: Class of 2025 (7687)
Non-profit (5087)
Now hiring (47)
Obesity (465)
Opinion (286)
Ovarian cancer (96)
Pain (115)
Pancreatic cancer (114)
Parkinson's disease (191)
Partnered (25)
Patents (297)
Patient recruitment (142)
Peanut (54)
People (65593)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22857)
Phase II (32144)
Phase III (24198)
Pipeline (1606)
Policy (219)
Postmarket research (3552)
Preclinical (10319)
Press Release (72)
Prostate cancer (138)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (493)
Real estate (7398)
Recruiting (75)
Regulatory (27008)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (161)
Series B (107)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (36)
Startups (4298)
State (2)
Stomach cancer (16)
Supply chain (80)
Tariffs (63)
The Weekly (88)
Vaccines (878)
Venture capitalists (51)
Weight loss (316)
Women's health (48)
Worklife (20)
Date
Today (132)
Last 7 days (607)
Last 30 days (2782)
Last 365 days (34341)
2025 (16619)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (67)
Alaska (7)
Arizona (279)
Arkansas (14)
Asia (50421)
Australia (8864)
California (7470)
Canada (2305)
China (683)
Colorado (320)
Connecticut (338)
Delaware (192)
Europe (115682)
Florida (1104)
Georgia (255)
Hawaii (1)
Idaho (65)
Illinois (711)
India (32)
Indiana (373)
Iowa (18)
Japan (218)
Kansas (115)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1070)
Massachusetts (5713)
Michigan (268)
Minnesota (467)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (73)
New Jersey (2083)
New Mexico (31)
New York (2101)
North Carolina (1211)
North Dakota (10)
Northern California (3222)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1600)
Puerto Rico (18)
Rhode Island (39)
South America (1653)
South Carolina (34)
South Dakota (1)
Southern California (2754)
Tennessee (123)
Texas (1126)
United States (28243)
Utah (222)
Virginia (200)
Washington D.C. (80)
Washington State (659)
West Virginia (4)
Wisconsin (82)
There are 851,080 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years
June 18, 2025
·
8 min read
Press Releases
Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million
June 18, 2025
·
2 min read
Press Releases
LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials
June 18, 2025
·
3 min read
Press Releases
Year-End Report 2024/2025
June 18, 2025
·
9 min read
Press Releases
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
June 18, 2025
·
3 min read
Press Releases
Steri-Tek to boost sterilization capacity of its Texas-based center fivefold with IBA’s X-ray irradiation system
June 18, 2025
·
3 min read
Press Releases
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
June 18, 2025
·
6 min read
Press Releases
Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide
June 18, 2025
·
2 min read
Press Releases
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
June 18, 2025
·
6 min read
Press Releases
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
June 18, 2025
·
9 min read
1 of 85,108
Next
